Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Invested Capital (2016 - 2025)

Historic Invested Capital for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to $56.6 million.

  • iBio's Invested Capital rose 30256.23% to $56.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $56.6 million, marking a year-over-year increase of 30256.23%. This contributed to the annual value of $14.9 million for FY2025, which is 3049.95% down from last year.
  • Per iBio's latest filing, its Invested Capital stood at $56.6 million for Q4 2025, which was up 30256.23% from $56.1 million recorded in Q3 2025.
  • iBio's Invested Capital's 5-year high stood at $108.6 million during Q2 2021, with a 5-year trough of $9.2 million in Q4 2023.
  • Moreover, its 5-year median value for Invested Capital was $23.2 million (2024), whereas its average is $44.4 million.
  • In the last 5 years, iBio's Invested Capital surged by 254922.92% in 2021 and then tumbled by 7922.36% in 2022.
  • iBio's Invested Capital (Quarter) stood at $90.6 million in 2021, then crashed by 79.22% to $18.8 million in 2022, then crashed by 51.14% to $9.2 million in 2023, then surged by 52.77% to $14.0 million in 2024, then surged by 302.56% to $56.6 million in 2025.
  • Its Invested Capital stands at $56.6 million for Q4 2025, versus $56.1 million for Q3 2025 and $14.9 million for Q2 2025.